SD Biosensor

SD Biosensor Assets per Share

The Total Assets per Share of SD Biosensor (137310.KS) as of Oct 31, 2026 is 26,535.58 KRW. In the previous year, Total Assets per Share was 31,819.79 KRW — a change of -16.61% (lower).

Assets per Share

26,535.58KRW

YoY

-16.61%

Last updated:

Total Assets per Share of SD Biosensor is 2025 26,535.58 KRW. Total Assets per Share of SD Biosensor was 2024 31,819.79 KRW. It decreases by -16.61% lower compared to the previous year.

The SD Biosensor Assets per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Assets per Share
Date
Assets per Share
Jan 1, 2019
1,388.83 KRW
Jan 1, 2020
11,960.87 KRW
Jan 1, 2021
24,591.32 KRW
Jan 1, 2022
26,692.72 KRW
Jan 1, 2023
31,004.48 KRW
Jan 1, 2024
31,819.79 KRW
Jan 1, 2025
26,535.58 KRW
The SD Biosensor Assets per Share history
YEARAssets per ShareYoY
26,535.58KRW-16.61%
31,819.79KRW+2.63%
31,004.48KRW+16.15%
26,692.72KRW+8.55%
24,591.32KRW+105.60%
11,960.87KRW+761.22%
1,388.83KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SD Biosensor Stock analysis

What does SD Biosensor do? SD Biosensor Inc generates revenue through the development and manufacturing of cholesterol and blood glucose testing equipment. The company sells rapid immunochemical diagnosis products, immunochemical fluorescence diagnosis products, molecular diagnosis products, and enzyme immunological reaction diagnosis products. These products are distributed domestically and internationally, targeting healthcare providers and consumers in the immunochemical, molecular, and point-of-care diagnosis sectors. The firm focuses on self blood glucose measurement and other diagnostic solutions for medical use. The company's product portfolio includes POCTs, which are used for point-of-care testing in medical settings. SD Biosensor Inc's offerings serve both the domestic market and overseas markets, with a strong emphasis on diagnostic equipment for healthcare applications. Their business model relies on the sale of these specialized medical devices to hospitals, clinics, and individual consumers seeking home health monitoring solutions. Revenue streams are derived from the research, development, and sale of diagnostic products, including immunochemical and molecular diagnosis tools. The firm's products are designed for use in clinical and self-testing environments, supporting both professional healthcare services and personal health management. SD Biosensor Inc's market segments include healthcare institutions and end-users requiring diagnostic testing for cholesterol, blood glucose, and other medical conditions. SD Biosensor is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SD Biosensor stock

Total Assets per Share of SD Biosensor is 26,535.58 KRW in 2025.

Total Assets per Share of SD Biosensor changed from 31,819.79 KRW to 26,535.58 KRW, representing a -16.61% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Assets per Share SD Biosensor since 2006 – with annual values, charts, and detailed analysis.

Assets per share divides total assets by shares outstanding, indicating the total resource base backing each share of stock.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — SD Biosensor

All Key Metrics — SD Biosensor